E-Conf Scientific Committee

Bin Ye

Vice President,Clinical Biomarker & Translational Medicine, Shenogen Pharma Group, Beijing, China

Dr. Bin Ye graduated from Weizmann Institute, Israel in 1998, followed his Post.Doc training in Harvard Medical School, was promoted as Assistant Professor in Brigham Women?s Hospital/Dana-Farber Cancer Center in 2008 with several competitive Cancer Research awards. He has contributed more than >40 original research papers and 7 patents Since 2011, Dr. Ye acted as senior Investigator and led China Biomarker Development (BMD) outsourcing at Novartis in early phase global trials. Dr. Ye jointed in Shenogen Pharma lead biomarker informatics and Translation Medicine in first-in-class icaritin development program from phase I to III and focus on immune therapy.